Expression and its significance of pituitary tumor transforming gene PTTG in NHL

Ke LI,Mei-zuo ZHONG,Jian-huang LI,Xing YU

DOI: https://doi.org/10.3969/j.issn.1673-5269.2007.24.008

2007-01-01

Abstract:Objective: To study the expression of pituitary tumor transforming gene PTTG in NHL and explore the correlation among its overexpression and clinicopathological parameters of NHL. Methods: Fifty cases of NHL and 20 cases of benign lymphademopathy were studied. PTTG expression was measured at both mRNA level and protein level by hybridization in situ and immunohistochemistry, respectively. Results: The positive expression rates of PTTG mRNA in malignant NHL and benign lymphademopathy were 54.0% (27/50) and 20.0% (4/20), respectively. The positive expression rates of PTTG protein in malignant NHL and benign lymphademopathy were 50.0% (25/50) and 15.0% (3/20), respectively. The positive expression rates and expression grades of both PTTGmRNA and its protein in NHL were significantly higher than those in benign lymphademopathy. The expression grade of PTTGmRNA was positively related to the tumor histopathologic grade and clinical stage (r = 0.366, P = 0.009; r = 0.438,P = 0.001). The expression of PTTG mRNA was related to the expression grade of PTTG protein in NHL (r = 0.831, P < 0.01). There was a negative correlation between the expression of PTTGmRNA and NHL recent effects (r = - 0.354, P < 0.05). Conclutions: There are overexpressions of PTTG and its protein in NHL. The expression of PTTG is related to NHL biology behavior.